@article{6dd835b7b48f489686c0aad4cc3572d5,
title = "Reducing vascular disease risk in the type 2 diabetic patient",
author = "Brown, {W. Virgil} and Goldberg, {Ronald B.} and Maria Lopes-Virella and Peter Reaven",
note = "Funding Information: Dr. Virgil Brown has received honoraria related to consulting from Bristol-Myers Squibb; Pfizer Inc.; Anthera; Genzyme Therapeutics; InVasc Therapeutics; and Twine Clinical. Dr. Brown has received honoraria related to speaking from Abbott Laboratories and Merck & Co. Dr. Ronald Goldberg has received honoraria related to speaking from Merck & Co.; GlaxoSmithKline; and Daiichi Sankyo. Dr. Goldberg has received honoraria related to consulting from GlaxoSmithKline; Daiichi Sankyo; and Pfizer Inc. Dr. Goldberg has received research grants from Abbott Laboratories; GlaxoSmithKline; and Roche Diagnostics. Dr. Maria Lopes-Virella has received honoraria related to consulting from Daiichi Sankyo. Dr. Peter Reaven has received honoraria related to speaking from Merck & Co. and has received honoraria related to consulting from Bristol Myers-Squibb. Dr. Reaven has received research grants from Eli Lilly & Co. and Amylin Pharmaceuticals Inc.",
year = "2011",
doi = "10.1016/j.jacl.2010.11.005",
language = "English (US)",
volume = "5",
pages = "3--11",
journal = "Journal of Clinical Lipidology",
issn = "1933-2874",
publisher = "Elsevier BV",
number = "1",
}
